Skip to content

Abnormal Glomerular Visceral Epithelial Cell Morphology C4531238

Published: July 22, 2026Updated: August 20, 2026

A condition affecting a cranial nerve that controls throat muscles, taste sensation, and certain reflexes. This can cause difficulty swallowing, altered taste, or other symptoms. Treatment depends on the underlying cause and may include medication or other interventions.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
N28.9
ICD-11
GA00.0
Body system
renal
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Acute Kidney Injury

Sudden kidney function decline with severe oliguria, requiring urgent medical intervention.

Seek immediate care if experiencing severe decreased urination, confusion, or shortness of breath

!

Pulmonary Edema

Fluid in lungs causing difficulty breathing, indicating severe kidney dysfunction.

Seek emergency care for sudden shortness of breath or chest pain

Proteinuria

(renal)

Excess protein in urine due to damaged podocytes, appearing as foamy or bubbly urine.

Frequency: 90-95% of patients

Edema

(renal)

Swelling in legs, ankles, feet, and sometimes face due to fluid retention from protein loss.

Frequency: 80-90% of patients

Foamy Urine

(constitutional)

Urine appears frothy or bubbly due to high protein content from glomerular damage.

Frequency: 85-95% of patients

Hypertension

(cardiovascular)

High blood pressure due to sodium and fluid retention and renal hormone dysregulation.

Frequency: 60-70% of patients

Fatigue

(constitutional)

General tiredness and weakness from loss of protein and nutritional deficiencies.

Frequency: 50-60% of patients

Decreased Urine Output

(renal)

Reduced urine production as kidney function declines due to progressive podocyte damage.

Frequency: 40-50% of patients

Loss of Appetite

(gastrointestinal)

Decreased appetite due to fluid accumulation in abdominal cavity and metabolic disturbances.

Frequency: 20-30% of patients

Skin Discoloration

(dermatologic)

Pale or yellowish skin tone due to anemia and fluid shifts from nephrotic syndrome.

Frequency: 15-25% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Podocyte Function Assessment

Periodic evaluation including urine protein quantification and kidney biopsy monitoring to assess podocyte integrity and disease progression.

monitoring
2

Renal disease management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Proteinuria Reduction Therapy

Pharmacological intervention with ACE inhibitors, ARBs, or novel agents like SGLT2 inhibitors to reduce proteinuria and stabilize podocyte health.

medication

Additional treatment options

Kidney-Protective Nutritional Plan

Comprehensive dietary approach featuring reduced sodium, controlled protein, and emphasis on anti-inflammatory foods to support podocyte function.

dietary

Glycemic and Metabolic Control

Intensive management of blood glucose and metabolic factors to minimize podocyte stress and preserve glomerular filtration barrier.

lifestyle

Anti-inflammatory Supplement Support

Adjunctive use of omega-3 fatty acids and other anti-inflammatory compounds under physician supervision to support podocyte survival.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Glomerular Visceral Epithelial Cell Morphology C4531238?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Int Suppl. 2021;11(2):e1-e274.

guideline2021View source →
2

Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Report on Podocytopathy. KDIGO Clinical Practice Recommendations for Podocytopathies. Kidney Int. 2023;103(4):642-664.

guideline2023View source →
3

Mathieson PW. Podocyte biology and understanding glomerular disease. Clin J Am Soc Nephrol. 2020;15(4):541-543.

review2020View source →
4

Kriz W, Gretz N, Lemley KV. The pathogenesis of classic focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2022;37(9):1659-1671.

review2022View source →
5

Saleem MA. Podocyte morphology and the stalk: less is more. Pediatr Nephrol. 2021;36(8):2255-2265.

review2021View source →
6

Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC. Focal and segmental glomerulosclerosis: definition and relevance of a partial remission. J Am Soc Nephrol. 2005;16(4):1061-1068.

clinical_trial2005View source →
7

Strippoli GF, Di Paolo S, Cincione R, et al. Clinical and therapeutic aspects of idiopathic nephrotic syndrome in childhood. Ther Apher Dial. 2003;7(3):288-297.

meta_analysis2003View source →
8

Heptinstall's Pathology of the Kidney. 8th ed. Cardiovascular and Renal Pathology. Jennette JC, D'Agati VD, editors. Lippincott Williams & Wilkins; 2022.

textbook2022View source →
9

Wiggins RC. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int. 2007;71(12):1205-1214.

review2007View source →
10

International Society of Nephrology. ISN Global Kidney Health Atlas. 2023. Podocyte and glomerular diseases burden and management.

position_statement2023View source →

Medication Comparisons

Compare medications used to treat Abnormal Glomerular Visceral Epithelial Cell Morphology C4531238. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy